10X Genomics, Inc.(NASDAQ : TXG)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||0.26%||7.68||0.7%||$536.86m|
|GILD||Gilead Sciences, Inc.||-0.55%||68.53||1.0%||$504.56m|
|REGN||Regeneron Pharmaceuticals, Inc.||-0.11%||516.62||2.7%||$432.65m|
|ALXN||Alexion Pharmaceuticals, Inc.||0.09%||173.49||2.0%||$412.31m|
|VRTX||Vertex Pharmaceuticals, Inc.||1.28%||217.09||1.9%||$311.54m|
|CRSP||CRISPR Therapeutics AG||5.58%||106.64||0.6%||$171.41m|
|BNGO||Bionano Genomics, Inc.||22.45%||5.40||0.0%||$162.77m|
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The companyâ€™s products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.